| 
|
NB Diagnostics has developed a range of biochemical assays for assessment of bone and cartilage disease.
These assays can be utilized as a tool in monitoring therapy and as an early prediction of the long-term skeletal
response to these therapies. Furthermore, the assays can shorten the time of pre-clinical and clinical studies
and thus represent significant value for the pharmaceutical and biotechnology industry.
|
Serum CrossLaps ELISA |
Bone Resorption Marker(CTX-I) For Clinical Trial & Patient Monitoring |
| N-MID Osteocalcin ELISA | Bone Formation Marker For Clinical Trials & Patient Monitoring Catalogue Product Insert reference |
| RatLaps ELISA | Bone Resorption Marker(CTX-I) For Monitoring Preclinical Trials Catalogue Product Insert reference |
| Rat-MID Osteocalcin ELISA |
Bone Formation Marker For Monitoring Preclinical Trials |
| CrossLaps for Culture ELISA |
Bone Resorption Marker(CTX-I) For Preclinical Research |
| Urine CartiLaps ELISA |
Cartilage Degradation Marker(CTX-II) For Clinical Research |
| Pre-Clinical CartiLaps ELISA |
Cartilage Degradation Marker(CTX-II) For Preclinical Research |
| ALPHA CrossLaps ELISA |
High-Turnover Bone Resorption Marker For Clinical Trials & Patient Monitoring |